iSpecimen Supports Hospital Validation of New Chemistry Analyzer
iSpecimen To Acquire Foldlab AI Assets For $4.5M, Including AI Models, Software And Intellectual Property
iSpecimen Says On August 26, Katharyn Field To Transition From Role As Chief Executive Officer; Shahin Behroyan Appointed As Chief Executive Officer
iSpecimen Completes Large-Scale International Cancer Research Order; Samples Shipped Within Three Weeks
iSpecimen Completes Global Cancer Research Project Of Cancer Blood Specimens; Samples Dispatched Within Three Weeks Of Getting Purchase Order
iSpecimen Inc. Announces Closing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants
E.F. Hutton & Co. Acts as Acts as Exclusive Placement Agent for $5.0 Million Public Offering for iSpecimen
E.F. Hutton & Co. Acts as Exclusive Placement Agent for $5.0 Million Public Offering for iSpecimen
iSpecimen Inc. Announces Pricing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants
E.F. Hutton & Co. Serves as Exclusive Placement Agent on iSpecimen Inc. $2.5 Million Private Placement
iSpecimen Inc. Announces Pricing of Approximately $2.5 Million Private Placement
Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times
Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending
iSpecimen Announces 1-for-40 Reverse Stock Split
Why iSpecimen Shares Are Surging On Friday?
iSpecimen shares are trading higher after the company announced it reduced its domestic shipments transit times.
iSpecimen Is Trending Overnight — Here's Why ISPC Stock Surged 56% In The After-Hours Session
iSpecimen Achieves 85% Reduction in Human Biospecimen Shipping Time
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.